期刊文献+

利用CHPS对我院282例药品不良反应的分析 被引量:1

Analysis on 282 Cases of Adverse Drug Reactions in Our Hospital Based on Chinese Hospital Pharmacovigilance System
原文传递
导出
摘要 目的:利用中国医院药物警戒系统(CHPS)对我院药品不良反应(ADR)发生的特点和规律进行分析,以便能更好地开展ADR监测。方法:收集本院2021年1月-12月通过CHPS上报国家药品不良反应监测系统的282例药品不良反应,对涉及ADR患者的性别、年龄、原患疾病、药品种类、药品剂型、累及器官/系统及临床表现、报告类型和转归情况进行统计分析。结果:282例ADR中女性患者发生率高于男性,45~64岁患者所占比例最高,为28.01%(128/457);原患疾病是冠状动脉粥样硬化性心脏病的患者药品不良反应发生率最高;发生不良反应最多的剂型是注射剂;抗肿瘤药引起的不良反应最多;ADR表现以皮肤及附件损害最为常见。结论:药品不良反应的发生与个体因素、药物和临床不合理使用等因素有关,应加强对药品临床使用的监管力度,确保患者用药安全有效。 Objective:To analyze the characteristics and regularity of adverse drug reactions(ADR)in our hospital by using China Hospital Pharmacovigilance System(CHPS),so as to better carry out ADR monitoring.Methods:A total of 282 cases of adverse drug reactions reported to the National Adverse Drug Reaction Monitoring System through CHPS in our hospital from January to December 2021 were collected.The gender,age,primary disease,drug type,drug dosage form,involved organs/systems and clinical manifestations,report types and outcomes of ADR patients were statistically analyzed.Results:Among the 282 cases of ADR,the incidence of female patients was higher than that of male patients,and the proportion of patients aged 45-64 years was the highest(28.01%,128/457).The incidence of adverse drug reactions was the highest in patients with coronary atherosclerotic heart disease.The dosage form with the most adverse reactions was injection;antitumor drugs caused the most adverse reactions.The most common manifestations of ADR were skin and accessories damage.Conclusion:The occurrence of adverse drug reactions is related to individual factors,drugs and unreasonable clinical use.The supervision of clinical use of drugs should be strengthened to ensure the safety and effectiveness of patients’medication.
作者 亢卫华 杨航 崔李平 王利杰 王秀丽 王振辉 KANG Weihua;YANG Hang;CUI Liping;WANG Lijie;WANG Xiuli;WANG Zhenhui(Department of Pharmacy,Jiaozuo Municipal the Second People’s Hospital,Jiaozuo 454001,Henan,China;School of Medicine,Henan Polytechnic University,Jiaozuo 454001,Henan,China)
出处 《中国药物滥用防治杂志》 CAS 2023年第7期1156-1158,1162,共4页 Chinese Journal of Drug Abuse Prevention and Treatment
基金 2020年度河南省高等学校青年骨干教师培训计划(编号:2020GGJS054)。
关键词 中国医院药物警戒系统 药品不良反应 用药安全性 Chinese Hospital Pharmacovigilance System Adverse drug reaction Drug safety
  • 相关文献

参考文献9

二级参考文献110

  • 1陈浩,冯雷,赵业婷,胡扬,都丽萍.北京地区老年患者使用中药注射剂的不良反应分析[J].中国药事,2020,34(3):357-362. 被引量:9
  • 2李韵梅,陈文戈,李辉盛,李晗,吴昊.基于中国医院药物警戒系统的药品安全性研究[J].名医,2020,0(4):216-216. 被引量:3
  • 3金朝辉,樊新星,钟光德,杨鳞,杨娟,管玫.左氧氟沙星不合理应用的危害与建议[J].中国药房,2007,18(17):1281-1283. 被引量:25
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5Gurbel PA, Bllden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the eft:ct of prett,eatment plateletreactivity [ J ]. Circulation,2003,107 : 2908-2913.
  • 6Angiolillo DJ,Femandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives [ J ]. J Am Coil Cardiol, 2007,49(14) : 1505-5016.
  • 7Campo G, Fileti L, de Cesare N, et al. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: A 3T/2R trial substudy[ J]. J Am Coll Cardiol. 2010,56(18) :1447-1455.
  • 8Singla A, Antonino MJ, Bliden KP, et al. The relation between platelet reaetivily andglyeemie eontrol in diabetic patients with cardiovascular disease on maintenance aslairin and elopidogreltherapy[J]. Am Heart J, 2009, 158(5):784.
  • 9Zhou H, Meng S, Zhao J, et al. Influence of genetic and non- genetic factors on the plasma concentrations of the clopidogrel metabolite (SR26334) among Chinese patients [ J ]. Clin Chim Acta. 2013,416: 50-53.
  • 10Zon JJ, Ding L, Tan J, et al. CYP2CI9 681G & gt; A polymor- phism and pharmacokinetics of clopidogrel in Chinese healthy volunteers[ J]. Pharmazie, 2012, 67 (9) :795-797.

共引文献786

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部